BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21346226)

  • 1. Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors.
    Barbus S; Tews B; Karra D; Hahn M; Radlwimmer B; Delhomme N; Hartmann C; Felsberg J; Krex D; Schackert G; Martinez R; Reifenberger G; Lichter P
    J Natl Cancer Inst; 2011 Apr; 103(7):598-606. PubMed ID: 21346226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.
    Xia SL; Wu ML; Li H; Wang JH; Chen NN; Chen XY; Kong QY; Sun Z; Liu J
    Oncotarget; 2015 Mar; 6(8):5889-902. PubMed ID: 25797252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid activation of peroxisome proliferation-activated receptor delta represses obesity and insulin resistance.
    Wolf G
    Nutr Rev; 2010 Jan; 68(1):67-70. PubMed ID: 20042001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid as cause of cell proliferation or cell growth inhibition depending on activation of one of two different nuclear receptors.
    Wolf G
    Nutr Rev; 2008 Jan; 66(1):55-9. PubMed ID: 18254885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR4A orphan nuclear receptors influence retinoic acid and docosahexaenoic acid signaling via up-regulation of fatty acid binding protein 5.
    Volakakis N; Joodmardi E; Perlmann T
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1186-91. PubMed ID: 19861119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
    Burton EC; Lamborn KR; Feuerstein BG; Prados M; Scott J; Forsyth P; Passe S; Jenkins RB; Aldape KD
    Cancer Res; 2002 Nov; 62(21):6205-10. PubMed ID: 12414648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
    Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glioblastomas: clinical study and search for prognostic factors].
    Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
    Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.
    Marko NF; Toms SA; Barnett GH; Weil R
    Genomics; 2008 May; 91(5):395-406. PubMed ID: 18343632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.
    Neurath KM; Keough MP; Mikkelsen T; Claffey KP
    Glia; 2006 May; 53(7):733-43. PubMed ID: 16518831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
    Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling.
    Collins CA; Watt FM
    Dev Biol; 2008 Dec; 324(1):55-67. PubMed ID: 18805411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guiding ligands to nuclear receptors.
    Michalik L; Wahli W
    Cell; 2007 May; 129(4):649-51. PubMed ID: 17512397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
    Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
    Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
    Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of c-Met expression in glioblastomas.
    Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
    Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.